SG10201912497WA - A blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings - Google Patents
A blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedingsInfo
- Publication number
- SG10201912497WA SG10201912497WA SG10201912497WA SG10201912497WA SG10201912497WA SG 10201912497W A SG10201912497W A SG 10201912497WA SG 10201912497W A SG10201912497W A SG 10201912497WA SG 10201912497W A SG10201912497W A SG 10201912497WA SG 10201912497W A SG10201912497W A SG 10201912497WA
- Authority
- SG
- Singapore
- Prior art keywords
- bleedings
- prophylaxis
- treatment
- blood coagulation
- coagulation factor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A61K38/385—Serum albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21022—Coagulation factor IXa (3.4.21.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21038—Coagulation factor XIIa (3.4.21.38)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17155420 | 2017-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201912497WA true SG10201912497WA (en) | 2020-02-27 |
Family
ID=58016586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201912497WA SG10201912497WA (en) | 2017-02-09 | 2018-02-09 | A blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11744880B2 (en) |
| EP (1) | EP3579857B1 (en) |
| JP (1) | JP7227905B2 (en) |
| KR (1) | KR102658958B1 (en) |
| CN (1) | CN110114074B (en) |
| AU (1) | AU2018217375B2 (en) |
| BR (1) | BR112019012772A2 (en) |
| CA (1) | CA3046406C (en) |
| DK (1) | DK3579857T3 (en) |
| ES (1) | ES2913934T3 (en) |
| PL (1) | PL3579857T3 (en) |
| SG (1) | SG10201912497WA (en) |
| WO (1) | WO2018146235A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113929741A (en) * | 2020-06-29 | 2022-01-14 | 首都医科大学 | warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA 1 and synthesis, activity and application thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663164A (en) * | 1980-01-28 | 1987-05-05 | Baxter Travenol Laboratories, Inc. | Aqueous compositions for treating blood clotting factor inhibitors |
| DE3101752A1 (en) | 1981-01-21 | 1982-08-26 | Behringwerke Ag, 3550 Marburg | "METHOD FOR PURIFYING THE BLOOD COAGINING FACTORS II, VII, IX AND / OR X AND PREPARATIONS PRODUCED THEREFORE" |
| DE3336631A1 (en) * | 1983-10-08 | 1985-04-18 | Behringwerke Ag, 3550 Marburg | METHOD FOR THE PASTEURIZATION OF PLASMA OR CONCENTRATES OF THE BLOOD COAGINING FACTORS II, VII, IX AND X |
| DE3622642A1 (en) * | 1986-07-05 | 1988-01-14 | Behringwerke Ag | ONE-COMPONENT TISSUE ADHESIVE AND METHOD FOR THE PRODUCTION THEREOF |
| DE59712322D1 (en) * | 1996-03-20 | 2005-06-30 | Baxter Ag | Pharmaceutical preparation for the treatment of blood clotting disorders |
| AT409334B (en) | 1997-09-19 | 2002-07-25 | Immuno Ag | PHARMACEUTICAL PREPARATION CONTAINING VITAMIN K-DEPENDENT INDIVIDUAL FACTORS |
| CN101317855A (en) | 2003-01-27 | 2008-12-10 | 哈维斯特技术公司 | Autologous or homologous coagulant produced from anticoagulated whole blood |
| FR2946348B1 (en) * | 2009-06-05 | 2011-08-05 | Lab Francais Du Fractionnement | PROCESS FOR PREPARING A HIGH-DEPTH PURITY PROTHROMBIC COMPLEX COMPOSITION |
| CN103221061A (en) * | 2010-10-06 | 2013-07-24 | 米迪缪尼有限公司 | Factor II and fibrinogen for treatment of haemostatic disorders |
| TWI653047B (en) * | 2014-03-14 | 2019-03-11 | 百特製藥公司 | Composition of human prothrombin and activating factor X for promoting hemostasis in the treatment of hemorrhagic disorders |
| CN107690333B (en) * | 2015-06-10 | 2021-12-17 | 赢创运营有限公司 | Method for preparing powder containing human coagulation factor protein and lactic acid polymer |
-
2018
- 2018-02-09 CA CA3046406A patent/CA3046406C/en active Active
- 2018-02-09 JP JP2019532137A patent/JP7227905B2/en active Active
- 2018-02-09 CN CN201880005539.2A patent/CN110114074B/en active Active
- 2018-02-09 EP EP18703026.7A patent/EP3579857B1/en active Active
- 2018-02-09 ES ES18703026T patent/ES2913934T3/en active Active
- 2018-02-09 US US16/474,803 patent/US11744880B2/en active Active
- 2018-02-09 PL PL18703026.7T patent/PL3579857T3/en unknown
- 2018-02-09 BR BR112019012772A patent/BR112019012772A2/en unknown
- 2018-02-09 DK DK18703026.7T patent/DK3579857T3/en active
- 2018-02-09 KR KR1020197018871A patent/KR102658958B1/en active IP Right Grant
- 2018-02-09 WO PCT/EP2018/053240 patent/WO2018146235A1/en unknown
- 2018-02-09 AU AU2018217375A patent/AU2018217375B2/en active Active
- 2018-02-09 SG SG10201912497WA patent/SG10201912497WA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK3579857T3 (en) | 2022-06-07 |
| CA3046406A1 (en) | 2018-08-16 |
| WO2018146235A1 (en) | 2018-08-16 |
| KR102658958B1 (en) | 2024-04-22 |
| BR112019012772A2 (en) | 2019-12-10 |
| AU2018217375B2 (en) | 2024-04-18 |
| ES2913934T3 (en) | 2022-06-06 |
| CN110114074A (en) | 2019-08-09 |
| CN110114074B (en) | 2024-05-28 |
| US11744880B2 (en) | 2023-09-05 |
| PL3579857T3 (en) | 2022-07-25 |
| AU2018217375A1 (en) | 2019-06-27 |
| EP3579857B1 (en) | 2022-04-06 |
| EP3579857A1 (en) | 2019-12-18 |
| CA3046406C (en) | 2024-01-30 |
| WO2018146235A8 (en) | 2019-05-09 |
| KR20190111912A (en) | 2019-10-02 |
| JP7227905B2 (en) | 2023-02-22 |
| JP2020506880A (en) | 2020-03-05 |
| US20190351028A1 (en) | 2019-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU201810677S (en) | Skin treatment article | |
| AU201714140S (en) | Skin treatment article | |
| ZA201700459B (en) | Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viii | |
| AU201714143S (en) | Skin treatment article | |
| AU201810686S (en) | Skin treatment article | |
| PL3577135T3 (en) | A pharmaceutical composition for use in the treatment or prevention of c5-related diseases | |
| SI3377637T1 (en) | Compositions for use in methods for the treatment of wounds, disorders, and diseases of the skin | |
| IL254142B (en) | Tradipitant for use in the treatment of a tradipitant-responsive disease or condition | |
| AU201810683S (en) | Skin treatment article | |
| AU201810685S (en) | Skin treatment article | |
| AU201810689S (en) | Skin treatment article | |
| AU201714141S (en) | Skin treatment article | |
| AU201810687S (en) | Skin treatment article | |
| PT3197290T (en) | A fish feed and its use in the prophylaxis and treatment of haemorrhagic smolt syndrome (hss) in salmonidae | |
| GB2542155B (en) | Use of cannabidiol in the treatment of mental disorders | |
| HK1257240A1 (en) | Medicine for preventing and treating tissue injury caused by abnormal fat deposition and use of the medicine | |
| LT3307277T (en) | Single-stranded oligonucleotides for use in the medical treatment of skin disorders | |
| GB201519557D0 (en) | Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions | |
| EP3518951C0 (en) | Compositions for use in the treatment of osteoporis and bone fractures | |
| IL264600B (en) | Knife for use in medical treatment | |
| SG10201912497WA (en) | A blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings | |
| ZA201807692B (en) | New use of product for skin treatment | |
| AU201810676S (en) | Skin treatment article | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism |